Compare SKM & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKM | ELAN |
|---|---|---|
| Founded | 1984 | 1954 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 12.7B |
| IPO Year | 1999 | 2018 |
| Metric | SKM | ELAN |
|---|---|---|
| Price | $36.36 | $22.99 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 9 |
| Target Price | N/A | ★ $27.63 |
| AVG Volume (30 Days) | 1.2M | ★ 5.3M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.49% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $4.51 | $8.21 |
| Revenue Next Year | $1.85 | $5.29 |
| P/E Ratio | $31.64 | ★ N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $19.66 | $8.02 |
| 52 Week High | $36.17 | $27.72 |
| Indicator | SKM | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 73.50 | 43.74 |
| Support Level | $20.63 | $22.17 |
| Resistance Level | N/A | $25.65 |
| Average True Range (ATR) | 1.12 | 1.02 |
| MACD | 0.73 | -0.07 |
| Stochastic Oscillator | 95.85 | 25.84 |
SK Telecom is South Korea's largest wireless telecom operator, with 32 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 7.2 million broadband customers and 9.5 million pay TV customers (6.7 million IPTV and 2.8 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production as well as developing e-commerce and internet platform businesses, these were all spun off into the separate, SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.